ATE374245T1 - Leere kapsiden (vlps(-vp4)) von die infektiöse bursitis verusachenden virus (ibdv), verfahren zu ihrer herstellung und anwendungen - Google Patents
Leere kapsiden (vlps(-vp4)) von die infektiöse bursitis verusachenden virus (ibdv), verfahren zu ihrer herstellung und anwendungenInfo
- Publication number
- ATE374245T1 ATE374245T1 AT05706999T AT05706999T ATE374245T1 AT E374245 T1 ATE374245 T1 AT E374245T1 AT 05706999 T AT05706999 T AT 05706999T AT 05706999 T AT05706999 T AT 05706999T AT E374245 T1 ATE374245 T1 AT E374245T1
- Authority
- AT
- Austria
- Prior art keywords
- ibdv
- vlps
- applications
- preparation
- empty capsids
- Prior art date
Links
- 241000702626 Infectious bursal disease virus Species 0.000 title abstract 5
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 206010006811 Bursitis Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 230000002458 infectious effect Effects 0.000 title 1
- 210000000234 capsid Anatomy 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 101500001538 Avian infectious bursal disease virus Capsid protein VP3 Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/045—Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10023—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200400121A ES2307346B1 (es) | 2004-01-21 | 2004-01-21 | Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE374245T1 true ATE374245T1 (de) | 2007-10-15 |
Family
ID=34802832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05706999T ATE374245T1 (de) | 2004-01-21 | 2005-01-21 | Leere kapsiden (vlps(-vp4)) von die infektiöse bursitis verusachenden virus (ibdv), verfahren zu ihrer herstellung und anwendungen |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090208528A1 (de) |
EP (1) | EP1706485B1 (de) |
AT (1) | ATE374245T1 (de) |
DE (1) | DE602005002621T2 (de) |
ES (2) | ES2307346B1 (de) |
WO (1) | WO2005071068A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2310062B1 (es) | 2005-07-15 | 2009-11-13 | Bionostra, S.L. | Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones. |
EP2407534A1 (de) | 2010-07-14 | 2012-01-18 | Neo Virnatech, S.L. | Verfahren und Reagenzien zum Erhalt von transkriptionell aktiven virusähnlichen Artikeln und rekombinante Virionen |
EP2505640A1 (de) | 2011-03-29 | 2012-10-03 | Neo Virnatech, S.L. | Impfstoffzusammensetzungen für vom Birnavirus übertragenen Krankheiten |
EP2870238A4 (de) * | 2012-07-05 | 2016-03-09 | Ohio State Innovation Foundation | Zusammensetzungen und verfahren in zusammenhang mit viralen impfstoffen |
US10086062B2 (en) | 2012-07-05 | 2018-10-02 | Ohio State Innovation Foundation | Infectious pancreatic necrosis virus (IPNV) vaccine compositions |
CN109134668A (zh) * | 2018-09-19 | 2019-01-04 | 天康生物股份有限公司 | 鸡传染性法氏囊病病毒的融合蛋白及其制备方法、应用、表达***和疫苗 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614409A (en) * | 1989-05-30 | 1997-03-25 | Commonwealth Scientific And Industrial Research Organisation | Production of IBDV VP2 in highly immunogenic form |
US5641490A (en) * | 1991-03-07 | 1997-06-24 | Virogenetics Corporation | Infectious bursal disease virus recombinant poxvirus vaccine |
DE69223406T2 (de) * | 1991-06-19 | 1998-06-25 | New York Medical College | M-Protein des Influenzavirus als antivirales Mittel |
US5658572A (en) * | 1991-07-26 | 1997-08-19 | Virogenetics Corporation | Infectious bursal disease virus recombinant poxvirus vaccine |
US5290686A (en) * | 1991-07-31 | 1994-03-01 | The United States Of America As Represented By The Department Of Health And Human Services | Expression of influenza a M2 protein in baculovirus |
US5605792A (en) * | 1993-11-04 | 1997-02-25 | The Ohio State University Research Foundation | Infectious bursal disease virus VP2 fusion protein expressed by baculovirus, use as diagnostic |
US5788970A (en) * | 1994-03-29 | 1998-08-04 | The University Of Maryland College Park | Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon |
AT402898B (de) * | 1994-08-08 | 1997-09-25 | Int Centre Genetic Eng & Bio | Molekulares präsentiersystem |
EP0783038B1 (de) * | 1996-01-02 | 2007-04-04 | Institut Pasteur | Rekombinante virale Pseudopartikeln und deren Verwendung als Impfstoff oder als antitumorale Wirkstoff |
US5871744A (en) * | 1996-09-05 | 1999-02-16 | University Of Maryland-Biotechnology Inst. | Method for generating birnavirus from synthetic RNA transcripts |
US5916879A (en) * | 1996-11-12 | 1999-06-29 | St. Jude Children's Research Hospital | DNA transcription unit vaccines that protect against avian influenza viruses and methods of use thereof |
CA2238659C (en) * | 1997-05-26 | 2010-12-14 | Akzo Nobel N.V. | Recombinant birnavirus vaccine |
US6596280B1 (en) * | 1997-07-31 | 2003-07-22 | University Of Maryland Biotechnology Institute | Method for generating birnavirus from synthetic RNA transcripts |
US6169175B1 (en) * | 1997-08-06 | 2001-01-02 | Centers For Disease Control And Prevention | Preparation and use of recombinant influenza A virus M2 construct vaccines |
US6231868B1 (en) * | 1997-09-30 | 2001-05-15 | University Of Maryland-Biotechnology Institute | Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts |
US6406843B1 (en) * | 1998-02-27 | 2002-06-18 | University Of Arkansas | Poultry virus isolates and method |
WO1999050419A2 (en) * | 1998-03-31 | 1999-10-07 | University Of Maryland Biotechnology Institute | A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts |
US6114112A (en) * | 1998-05-21 | 2000-09-05 | The Ohio State University | Method of making immunogenic compositions for infectious bursal disease virus |
CA2360347C (en) * | 1998-12-31 | 2013-05-07 | Chiron Corporation | Improved expression of hiv polypeptides and production of virus-like particles |
US6528063B2 (en) * | 1999-01-04 | 2003-03-04 | Rahan Meristem | Recombinant vaccines against IBDV |
EP1069187A1 (de) * | 1999-07-14 | 2001-01-17 | Stichting Dienst Landbouwkundig Onderzoek | Mosaik-Virus der infectiösen Bursal-Krankheit enthaltender Impfstoff |
FR2806087B1 (fr) * | 2000-03-07 | 2002-10-18 | Agronomique Inst Nat Rech | Particules pseudovirales de rotavirus et leur utilisation pour vectoriser des proteines ou des acides nucleiques |
AU2001255336B8 (en) * | 2000-04-14 | 2005-10-20 | Wisconsin Alumni Research Foundation | Viruses comprising mutation ion channel protein |
US20020165176A1 (en) * | 2000-05-01 | 2002-11-07 | Haynes Joel R. | Nucleic acid immunization |
CA2407897A1 (en) * | 2000-05-05 | 2001-11-15 | Cytos Biotechnology Ag | Molecular antigen arrays and vaccines |
EP1296710A4 (de) * | 2000-06-19 | 2004-05-12 | Rahan Meristem | Rekombinanter impfstoff gegen das für die bursal-krankheit verantwortliche virus(03.01.02) |
WO2002000885A2 (en) * | 2000-06-23 | 2002-01-03 | American Cyanamid Company | Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
DE60232577D1 (de) * | 2001-01-18 | 2009-07-23 | Vlaams Interuniv Inst Biotech | Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential |
FR2824327B1 (fr) * | 2001-05-02 | 2003-07-11 | Agronomique Inst Nat Rech | Particules pseudovirales de birnavirus |
WO2003013597A1 (en) * | 2001-08-10 | 2003-02-20 | University Of Maryland Biotechnology Institute | Sub-unit vaccine for infectious pancreatic necrosis virus |
US6764684B2 (en) * | 2001-09-28 | 2004-07-20 | Zeon Corporation | Avian herpesvirus-based recombinant infectious bursal disease vaccine |
AU2003242742B2 (en) * | 2002-06-20 | 2009-04-30 | Cytos Biotechnology Ag | Packaged virus-like particles for use as adjuvants: method of preparation and use |
US20060121468A1 (en) * | 2002-06-26 | 2006-06-08 | Allnutt F C T | Viruses and virus-like particles for multiple antigen and target display |
US20040223976A1 (en) * | 2003-03-07 | 2004-11-11 | Elisabetta Bianchi | Influenza virus vaccine |
WO2004112831A2 (en) * | 2003-05-28 | 2004-12-29 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines and gene therapy |
CN100404070C (zh) * | 2003-07-10 | 2008-07-23 | 赛托斯生物技术公司 | 包装的病毒样颗粒 |
US8592197B2 (en) * | 2003-07-11 | 2013-11-26 | Novavax, Inc. | Functional influenza virus-like particles (VLPs) |
WO2005116270A2 (en) * | 2004-05-18 | 2005-12-08 | Vical Incorporated | Influenza virus vaccine composition and method of use |
US7244432B2 (en) * | 2004-12-08 | 2007-07-17 | University Of Maryland Biotechnology Institute | Infectious bursal disease virus (IBDV) variant from Georgia |
-
2004
- 2004-01-21 ES ES200400121A patent/ES2307346B1/es not_active Withdrawn - After Issue
-
2005
- 2005-01-21 US US10/576,988 patent/US20090208528A1/en not_active Abandoned
- 2005-01-21 AT AT05706999T patent/ATE374245T1/de not_active IP Right Cessation
- 2005-01-21 ES ES05706999T patent/ES2294679T3/es active Active
- 2005-01-21 EP EP05706999A patent/EP1706485B1/de not_active Not-in-force
- 2005-01-21 WO PCT/EP2005/000694 patent/WO2005071068A1/en active Application Filing
- 2005-01-21 DE DE602005002621T patent/DE602005002621T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2307346B1 (es) | 2009-11-13 |
EP1706485A1 (de) | 2006-10-04 |
ES2294679T3 (es) | 2008-04-01 |
US20090208528A1 (en) | 2009-08-20 |
EP1706485B1 (de) | 2007-09-26 |
DE602005002621T2 (de) | 2008-07-24 |
WO2005071068A1 (en) | 2005-08-04 |
DE602005002621D1 (de) | 2007-11-08 |
ES2307346A1 (es) | 2008-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Afrough et al. | Emerging viruses and current strategies for vaccine intervention | |
ATE374245T1 (de) | Leere kapsiden (vlps(-vp4)) von die infektiöse bursitis verusachenden virus (ibdv), verfahren zu ihrer herstellung und anwendungen | |
DE602005013060D1 (de) | Chimärische leere capside des ibdv (infectious bursal disease virus), gewinnungsverfahren und anwendungen | |
WO2017015463A3 (en) | Infectious disease vaccines | |
ATE516345T1 (de) | Von ibdv (infectious bursal disease virus) abgeleitete chimäre leere virusähnliche partikel, verfahren zu deren herstellung und anwendungen | |
EP1526175A3 (de) | Coronavirus, Nukleinsäure, Protein, Verfahren zur Erzeugung der Impfstoffe, Medikamente und Diagnostika | |
JP2008503221A5 (de) | ||
JP2015524421A5 (de) | ||
TW200740454A (en) | Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus | |
JP2014532691A5 (de) | ||
RU2017126030A (ru) | Улучшенная вакцина против nd-ibd на основе вектора hvt | |
DK1881845T3 (da) | Nipah-virusvacciner | |
Ravikumar et al. | Vaccines against major poultry viral diseases: strategies to improve the breadth and protective efficacy | |
BRPI0816134A2 (pt) | Herpesvírus, sequência de dna, vetor, célula, vírus, método para produção de partículas infecciosas, partículas infecciosas, vacina, uso de herpesvírus ou da sequência de dna ou do vetor ou das partículas infecciosas, e, método para o tratamento preventivo e/ou terapêutico de uma doença. | |
CN105754959A (zh) | 表达dhav-1和dhav-3型vp1基因的ndv重组病毒及其应用 | |
AR047581A1 (es) | Vacunas de calicivirus felino | |
FI3244920T3 (fi) | Suu- ja sorkkatautirokote | |
RU2019102170A (ru) | Вирус утиного энтерита и его применение | |
AR081409A1 (es) | PARAPOXVIRUS RECOMBINANTE CONTENIENDO ADN HETERoLOGO DERIVADO DE UN VIRUS DE LA RABIA (RV) | |
WO2005112994A8 (en) | Nodavirus-vlp immunization composition | |
CL2010001175A1 (es) | Composicion de vacuna que comprende un antigeno de proteina viral 2 (vp-2) del virus causante de la enfermedad de la bursitis infecciosa (ibdv). | |
ATE427119T1 (de) | Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung | |
WO2019178288A3 (en) | Virus-like nanocapsid for oral delivery of insulin | |
WO2014008475A3 (en) | Compositions and methods related to viral vaccines | |
CN102272294A (zh) | 用于诱导病毒生长的组合物、方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |